查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1980806

全球栓塞治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Embolotherapy Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 175 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計栓塞治療市場將從 2025 年的 54.4 億美元成長到 2034 年的 112.4 億美元，2026 年至 2034 年的複合年成長率為 8.39%。

由於微創手術在各種疾病治療中的應用日益廣泛，全球栓塞術市場正經歷顯著成長。栓塞術廣泛用於阻斷腫瘤、異常血管或出血部位的血流，已成為腫瘤學、神經學和血管疾病的重要治療選擇。癌症和血管疾病發生率的上升是推動市場成長的主要因素。

栓塞材料和影像技術的進步提高了栓塞治療的安全性和有效性。微球、彈簧圈和液體栓塞劑等先進栓塞劑的研發，使得複雜疾病的治療更加精準。此外，醫療專業人員對微創療法益處的認知不斷提高，也推動了微創療法的廣泛應用。

由於介入放射學領域的持續研究和創新，栓塞治療市場預計未來將進一步擴張。先進影像系統的普及和專業治療中心的增加將推動市場成長。隨著醫療機構不斷優先考慮微創手術，栓塞治療有望成為全球日益重要的治療方法。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球栓塞治療市場：依產品分類

  • 市場分析、洞察與預測
  • 栓塞線圈
  • 栓塞劑
  • 可拆卸氣球
  • 栓塞塞系統
  • 輔助設備

第5章 全球栓塞治療市場：依應用領域分類

  • 市場分析、洞察與預測
  • 腫瘤學
  • 周邊血管疾病
  • 泌尿系統和腎臟病學
  • 神經病學
  • 消化器官系統疾病

第6章 全球栓塞治療市場：依手術方式分類

  • 市場分析、洞察與預測
  • 經導管動脈栓塞術
  • 經導管動脈放射乳劑/選擇性體內放射療法
  • 經動脈化療栓塞術

第7章 全球栓塞治療市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 醫院和診所
  • 門診手術中心
  • 其他最終用戶

第8章 全球栓塞治療市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Boston Medical Corporation
    • Terumo Corporation
    • Medtronic Plc
    • Johnson & Johnson
    • Stryker Corporation
    • Sirtex Medical Limited
    • Abbott Laboratories
    • Acandis GmbH
    • Balt Extrusion SAS
    • Cook Medical LLC
    • Kaneka Corporation
    • Penumbra Inc
    • Merit Medical Systems Inc
    • Meril Life Sciences Pvt. Ltd
    • Cardiva Medical Inc
簡介目錄
Product Code: VMR112115503

The Embolotherapy Market size is expected to reach USD 11.24 Billion in 2034 from USD 5.44 Billion (2025) growing at a CAGR of 8.39% during 2026-2034.

The global embolotherapy market is experiencing significant growth due to the increasing adoption of minimally invasive procedures for the treatment of various medical conditions. Embolotherapy is widely used to block blood flow to tumors, abnormal vessels, or bleeding sites, making it an important treatment option in oncology, neurology, and vascular disorders. The growing prevalence of cancer and vascular diseases is a key driver for the market.

Advancements in embolization materials and imaging technologies have improved the safety and effectiveness of embolotherapy procedures. The development of advanced embolic agents such as microspheres, coils, and liquid embolics has enabled more precise treatment of complex conditions. Additionally, increasing awareness among healthcare professionals about the benefits of minimally invasive therapies is encouraging wider adoption.

Looking ahead, the embolotherapy market is expected to expand further due to ongoing research and innovation in interventional radiology. The increasing availability of advanced imaging systems and specialized treatment centers will support market growth. As healthcare providers continue to prioritize minimally invasive procedures, embolotherapy is likely to become an increasingly important treatment approach worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Embolization Coil
  • Embolic Agents
  • Detachable Balloons
  • Embolic Plug Systems
  • Support Devices

By Application

  • Oncology
  • Peripheral Vascular Diseases
  • Urology and Nephrology
  • Neurology
  • GIT Disorders

By Procedure

  • Transcatheter Arterial Embolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • Transarterial Chemoembolization

By End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Other End Users

COMPANIES PROFILED

  • Boston Medical Corporation, Terumo Corporation, Medtronic plc, Johnson Johnson, Stryker Corporation, Sirtex Medical Limited, Abbott Laboratories, Acandis GmbH, Balt Extrusion SAS, Cook Medical LLC, Kaneka Corporation, Penumbra Inc, Merit Medical Systems Inc, Meril Life Sciences Pvt Ltd, Cardiva Medical Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL EMBOLOTHERAPY MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Embolization Coil Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Embolic Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Detachable Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Embolic Plug Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Support Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EMBOLOTHERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Peripheral Vascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Urology and Nephrology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. GIT Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EMBOLOTHERAPY MARKET: BY PROCEDURE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Procedure
  • 6.2. Transcatheter Arterial Embolization Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Transarterial Chemoembolization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EMBOLOTHERAPY MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EMBOLOTHERAPY MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Application
    • 8.2.3 By Procedure
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Application
    • 8.3.3 By Procedure
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Application
    • 8.4.3 By Procedure
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Application
    • 8.5.3 By Procedure
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Application
    • 8.6.3 By Procedure
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EMBOLOTHERAPY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Boston Medical Corporation
    • 10.2.2 Terumo Corporation
    • 10.2.3 Medtronic Plc
    • 10.2.4 Johnson & Johnson
    • 10.2.5 Stryker Corporation
    • 10.2.6 Sirtex Medical Limited
    • 10.2.7 Abbott Laboratories
    • 10.2.8 Acandis GmbH
    • 10.2.9 Balt Extrusion S.A.S
    • 10.2.10 Cook Medical LLC
    • 10.2.11 Kaneka Corporation
    • 10.2.12 Penumbra Inc
    • 10.2.13 Merit Medical Systems Inc
    • 10.2.14 Meril Life Sciences Pvt. Ltd
    • 10.2.15 Cardiva Medical Inc